PATENT CLAIM ANALYSIS

Application Number: 15991551
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2019-01
Patent Classification: ["536", "018100"]

Abstract:
Aspects of the invention relate to compounds, extracts and compositions thereof, and methods of using of the same, to treat neurodegenerative disorders and/or improve brain health. In certain embodiments, said compounds are pomegranate flavonoids.

Claim (Index 17):
A method of inhibiting aggregation of a peptide or protein, comprising the step of contacting the peptide or protein with an effective amount of Punicalin, Punicalagin, Pedunculagin, Tellimagrandin, Corilagin, Granatine A, Granatine B, Terminalin, Gallagyldilactone, Compound A or a compound of Formula I: or pharmaceutically acceptable salt, biologically active metabolite, solvate, hydrate, prodrug, enantiomer or stereoisomer thereof; wherein, independently for each occurrence, X is \u2003and R 1 , R 2  and R 3  are each independently hydrogen, alkyl, aralkyl, alkylcarboxy, or a sugar; or R 1  is hydrogen, alkyl, aralkyl, alkylcarboxy, \u2003or a sugar, R 2  is hydrogen or \u2003and R 3  is \u2003or R 1  is hydrogen, alkyl, aralkyl, alkylcarboxy, or a sugar, and R 2  and R 3  taken together are

Metadata:
- Claim Count in Document: 33.0
- Percentile: 93.0
- Lexical Diversity: 1.33333
- Patent Class: 536.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14584581', '12842750', '14606714', '11434726', '10415765']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6056173881364926
- 35 USC 102 Novelty (BERT): 0.5228738290573682
- Combined Prediction Score: 0.5973430322285802
- Mean Citation Score: 241.822546
- Max Citation Score: 346.82797
- Similarity Product: 244.77577907881616

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test